12.07
0.92%
+0.11
전일 마감가:
$11.96
열려 있는:
$11.98
하루 거래량:
488.99K
시가총액:
$857.13M
수익:
-
순이익/손실:
$-292.19M
주가수익비율:
-2.5146
EPS:
-4.8
순현금흐름:
$-208.41M
1주 성능:
-3.75%
1개월 성능:
-5.04%
6개월 성능:
+6.34%
1년 성능:
-54.64%
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
명칭
Zentalis Pharmaceuticals Inc
전화
212 433 3791
주소
530 Seventh Avenue, Suite 2201, New York, NY
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-07-12 | 개시 | Cowen | Outperform |
2022-04-06 | 개시 | Wells Fargo | Overweight |
2021-10-07 | 재개 | Jefferies | Buy |
2021-09-30 | 개시 | Stifel | Buy |
2021-09-29 | 개시 | Oppenheimer | Outperform |
2021-05-21 | 개시 | UBS | Buy |
2021-01-20 | 개시 | Wedbush | Outperform |
2020-09-29 | 개시 | Cantor Fitzgerald | Overweight |
2020-08-27 | 개시 | H.C. Wainwright | Buy |
2020-04-28 | 개시 | Guggenheim | Buy |
2020-04-28 | 개시 | Jefferies | Buy |
2020-04-28 | 개시 | Morgan Stanley | Overweight |
2020-04-28 | 개시 | SVB Leerink | Outperform |
모두보기
Zentalis Pharmaceuticals Inc 주식(ZNTL)의 최신 뉴스
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Shares Gap Up to $11.67 - MarketBeat
MarketBeat
Financial Metrics Exploration: Understanding Zentalis Pharmaceuticals Inc (ZNTL) Through Ratios – DWinneX - The Dwinnex
The Dwinnex
Nothing is Better Than Zentalis Pharmaceuticals Inc (ZNTL) stock at the moment – Sete News - SETE News
SETE News
(ZNTL) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Stock Traders Daily
ZNTL's 2023 Market Dance: Down -22.44% – Time to Invest? - The InvestChronicle
The InvestChronicle
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit - Yahoo Finance
Yahoo Finance
Zentalis Pharmaceuticals Inc (ZNTL) 재무 분석
Zentalis Pharmaceuticals Inc (ZNTL) 순이익 2024
ZNTL은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -292.19M 달러로 보고했으며, 전년대비 -23.39% 감소했습니다.
Zentalis Pharmaceuticals Inc (ZNTL) 현금흐름 2024
2023-12-31 종료 분기에 ZNTL은 현금흐름(지난 12개월)으로 -208.41M 달러를 기록했으며, 전년 대비 -25.32% 감소했습니다.
Zentalis Pharmaceuticals Inc (ZNTL) 주당 순이익 2024
ZNTL이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -4.54달러이며, 전년 대비 -0.22% 감소했습니다.
Zentalis Pharmaceuticals Inc 주식 (ZNTL) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Epperly Melissa B, | Chief Financial Officer |
Feb 12 '24 |
Sale |
11.44 |
2,573 |
29,435 |
451,449 |
Gallagher Cam | President |
Feb 12 '24 |
Sale |
11.44 |
1,173 |
13,419 |
643,277 |
Gallagher Cam | President |
Feb 02 '24 |
Sale |
11.54 |
11,552 |
133,310 |
644,450 |
Epperly Melissa B, | Chief Financial Officer |
Feb 02 '24 |
Sale |
11.54 |
8,669 |
100,040 |
454,022 |
Paul Andrea | Chief Legal Officer |
Feb 02 '24 |
Sale |
11.54 |
3,310 |
38,197 |
149,973 |
Lackner Mark | Chief Scientific Officer |
Feb 02 '24 |
Sale |
11.54 |
1,585 |
18,291 |
195,728 |
Blackwell Kimberly | Chief Executive Officer |
Nov 13 '23 |
Buy |
10.29 |
5,000 |
51,448 |
254,800 |
Johnson David Michael | Director |
Nov 10 '23 |
Buy |
9.88 |
17,000 |
167,943 |
144,389 |
Brownstein Carrie | Chief Medical Officer |
Oct 04 '23 |
Sale |
19.50 |
10,628 |
207,298 |
105,685 |
Bunker Kevin D. | Chief Scientific Officer |
Oct 04 '23 |
Sale |
19.50 |
6,068 |
118,355 |
859,089 |
자본화:
|
볼륨(24시간):